Short Interest in SeaStar Medical Holding Co. (NASDAQ:ICU) Expands By 79.0%

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a large growth in short interest in September. As of September 30th, there was short interest totalling 212,100 shares, a growth of 79.0% from the September 15th total of 118,500 shares. Based on an average daily trading volume, of 134,700 shares, the days-to-cover ratio is currently 1.6 days. Approximately 5.5% of the shares of the company are short sold.

SeaStar Medical Stock Up 2.8 %

Shares of SeaStar Medical stock traded up $0.11 during trading hours on Friday, reaching $4.06. 48,195 shares of the stock traded hands, compared to its average volume of 207,567. The company has a 50 day moving average price of $5.33 and a 200 day moving average price of $8.62. The firm has a market capitalization of $13.08 million, a price-to-earnings ratio of -0.16 and a beta of -1.14. SeaStar Medical has a one year low of $3.25 and a one year high of $42.92.

SeaStar Medical (NASDAQ:ICU) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($1.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.41) by $0.38.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.